CYTOKINETICS INC reports a Return on Equity (ROE) of 100.37%.

What is CYTK's dividend yield?

CYTOKINETICS INC offers a dividend yield of 0.00%.

What is CYTK's Deepscope Quality Score?

Deepscope rates CYTK's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CYTK?

Deepscope's AI Timing Score for CYTK is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CYTK belong to?

CYTOKINETICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu CYTK (NASDAQ) | CYTOKINETICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

CYTK

CYTOKINETICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 80

USD 70.71

-0.20 (-0.28%) Day Change

Watchlist Portfolio Compare Chart

-1.43

D/E

100.4%

ROE

-65.2%

ROA

0.00%

Div Yield

CYTOKINETICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 70.71 Price -0.20 (-0.28%) Day Change	NEWS SCORE: 80

CYTK Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROA tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	80
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	70.71
PBV / Sector	-11.65 / 4.48
Earning Per Share	-6.09

PE / Sector	N/A / 16.68
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	195.45 M GREAT
Average 1W Daily Value	124.41 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-784.02 / 450.37
NPM Average (%) / Sector	-2,453.31 / -1,506.30
NPM Change Average (%) / Sector	365.27 / 4,941.44 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-65.15 / 30.83
ROA Average (%) / Sector	-52.90 / -347.12
ROA Change Average (%) / Sector	20.42 / 5,126.35 GREAT
ROE (%) / Sector	100.37 / -3.04 GREAT
ROE Average (%) / Sector	230.31 / 40.76 GREAT
ROE Change Average (%) / Sector	17.29 / 2,110.63 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Chi tiết đăng ký

Analyze Date	2026-06-04 09:24:23
Symbol	CYTK
Name	CYTOKINETICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	135.77 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	9,627.49 / 8,483.11

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Phone: 650 624 3000

Website: https://www.cytokinetics.com

Employees: 673

Sector: Healthcare >> Biotechnology

Description: Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.